SkyView Investment Advisors LLC Sells 2,719 Shares of UnitedHealth Group Incorporated $UNH

SkyView Investment Advisors LLC decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 73.1% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,000 shares of the healthcare conglomerate’s stock after selling 2,719 shares during the period. SkyView Investment Advisors LLC’s holdings in UnitedHealth Group were worth $416,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Sarver Vrooman Wealth Advisors bought a new position in shares of UnitedHealth Group in the fourth quarter valued at about $25,000. Nalls Sherbakoff Group LLC bought a new position in UnitedHealth Group in the 4th quarter valued at about $27,000. Lifetime Wealth Management P.C. acquired a new stake in UnitedHealth Group during the fourth quarter worth approximately $29,000. Aberdeen Wealth Management LLC acquired a new position in shares of UnitedHealth Group in the second quarter valued at approximately $31,000. Finally, Merkkuri Wealth Advisors LLC acquired a new stake in UnitedHealth Group during the 1st quarter worth approximately $33,000. Institutional investors own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

UNH has been the topic of several recent research reports. Robert W. Baird upgraded UnitedHealth Group from an “underperform” rating to a “neutral” rating and increased their price objective for the stock from $287.00 to $453.00 in a research report on Thursday, July 16th. Wells Fargo & Company upped their price target on shares of UnitedHealth Group from $397.00 to $485.00 and gave the company an “overweight” rating in a research note on Monday, July 13th. Piper Sandler set a $477.00 price objective on shares of UnitedHealth Group in a research note on Thursday, July 16th. HC Wainwright set a $492.00 target price on shares of UnitedHealth Group in a report on Wednesday, May 27th. Finally, Leerink Partners boosted their price target on UnitedHealth Group from $400.00 to $462.00 and gave the company an “outperform” rating in a research note on Wednesday, June 17th. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $456.56.

Insider Activity at UnitedHealth Group

In other news, CEO Patrick Conway sold 1,169 shares of the firm’s stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the sale, the chief executive officer directly owned 15,328 shares in the company, valued at approximately $5,977,920. This trade represents a 7.09% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 0.19% of the company’s stock.

UnitedHealth Group Trading Up 1.1%

UNH opened at $383.23 on Tuesday. The company has a quick ratio of 0.78, a current ratio of 0.78 and a debt-to-equity ratio of 0.66. UnitedHealth Group Incorporated has a twelve month low of $255.96 and a twelve month high of $461.62. The stock has a market capitalization of $343.99 billion, a price-to-earnings ratio of 24.66, a P/E/G ratio of 1.43 and a beta of 0.61. The company has a 50-day simple moving average of $407.88 and a 200 day simple moving average of $369.08.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 EPS for the quarter, beating the consensus estimate of $4.94 by $1.44. The company had revenue of $112.03 billion during the quarter, compared to analysts’ expectations of $110.81 billion. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The business’s revenue for the quarter was up .4% compared to the same quarter last year. During the same period in the previous year, the company earned $4.08 EPS. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Analysts predict that UnitedHealth Group Incorporated will post 19.82 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th will be given a $2.32 dividend. This represents a $9.28 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date is Monday, September 14th. UnitedHealth Group’s payout ratio is currently 59.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated is a diversified health care and well-being company headquartered in Minnetonka, Minnesota. Its operations are organized primarily through two businesses: UnitedHealthcare, which provides health benefit plans and services, and Optum, which delivers health care services, technology, pharmacy care and data-driven solutions.

UnitedHealthcare serves individuals, employers, government programs and other organizations through products that include employer-sponsored health plans, individual and family coverage, Medicare and Medicaid plans, dental and vision benefits, and related administrative services.